Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $9.01B | $9.55B | $10.2B | $9.27B | $8.47B | $10.5B | $10.6B | $9.21B | $9.38B | $8.75B |
| Revenue growth | — | 6.0% | 6.3% | -8.6% | -8.6% | 23.6% | 1.0% | -12.9% | 1.9% | -6.7% |
| Gross profit | $2.36B | $2.36B | $2.48B | $2.23B | $1.98B | $2.50B | $2.14B | $2.06B | $2.29B | $1.84B |
| Gross margin | 26.2% | 24.7% | 24.4% | 24.1% | 23.3% | 23.9% | 20.2% | 22.4% | 24.4% | 21.1% |
| Operating income | $1.38B | $1.53B | — | — | — | — | — | — | — | — |
| Operating margin | 15.4% | 16.0% | — | — | — | — | — | — | — | — |
| Net income | $854M | $1.38B | $1.08B | $759M | $478M | $857M | $793M | $894M | $905M | $474M |
| Net margin | 9.5% | 14.5% | 10.6% | 8.2% | 5.6% | 8.2% | 7.5% | 9.7% | 9.6% | 5.4% |
| EPS (diluted) | $5.75 | $9.47 | $7.56 | $5.48 | $3.50 | $6.25 | $6.35 | $7.49 | $7.67 | $4.10 |
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $1.39B | $1.66B | $1.54B | $1.50B | $1.46B | $1.62B | $975M | $1.37B | $1.29B | $970M |
| Capital expenditures | $626M | $649M | $528M | $425M | $383M | $555M | $611M | $828M | $599M | $546M |
| Free cash flow | $759M | $1.01B | $1.01B | $1.08B | $1.07B | $1.06B | $364M | $546M | $688M | $424M |
| Share buybacks | — | — | — | — | — | $900M | — | — | — | — |
| Dividends paid | $272M | $296M | $318M | $343M | $358M | $375M | $381M | $376M | $379M | $381M |
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $181M | $191M | $226M | $204M | $564M | $459M | $493M | $548M | $837M | $566M |
| Total assets | $15.5B | $16.0B | $16.0B | $16.0B | $16.1B | $15.5B | $14.7B | $14.6B | $15.2B | $14.9B |
| Total liabilities | $10.8B | $10.5B | $10.1B | $9.98B | $9.97B | $9.73B | $9.43B | $9.10B | $9.36B | $8.82B |
| Long-term debt | $6.31B | $6.15B | $5.92B | $5.61B | $5.27B | $4.41B | $4.03B | $4.30B | $4.57B | $4.20B |
| Shareholders' equity | $4.53B | $5.40B | $5.80B | $5.96B | $6.02B | $5.70B | $5.15B | $5.46B | $5.78B | $5.96B |
| Retained earnings | $5.72B | $6.80B | $7.57B | $7.96B | $8.08B | $8.56B | $8.97B | $9.49B | $10.0B | $10.1B |
| Shares (wtd avg diluted) | 148M | 146M | 143M | 139M | 137M | 137M | 125M | 119M | 118M | 116M |
Every figure is extracted from EASTMAN CHEMICAL CO’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.